These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Agranulocytosis due to new sustained-release procainamide. Berger BE; Hauser DJ Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823 [No Abstract] [Full Text] [Related]
14. Intrahepatic cholestasis due to hypersensitivity reaction to procainamide. Ahn CS; Tow DE Arch Intern Med; 1990 Dec; 150(12):2589-90. PubMed ID: 2244779 [TBL] [Abstract][Full Text] [Related]
15. Procainamide in acute myocardial infarction: a study on two different tablet preparations of sustained release type. Ihlen H; Ditlefsen L Curr Ther Res Clin Exp; 1975 Nov; 18(5):720-6. PubMed ID: 812650 [No Abstract] [Full Text] [Related]
16. Possible case of procainamide-induced intrahepatic cholestatic jaundice. Chuang LC; Tunier AP; Akhtar N; Levine SM Ann Pharmacother; 1993 Apr; 27(4):434-7. PubMed ID: 8477118 [TBL] [Abstract][Full Text] [Related]
17. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)]. Bliddal J Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996 [No Abstract] [Full Text] [Related]